(Q35068761)

6 August 2017

1 reference

title

Apolipoprotein E polymorphism and atherosclerosis (English)

1 reference

6 August 2017

author

Dimitri P Mikhailidis

series ordinal

3

object named as

Dimitri P Mikhailidis

1 reference

6 August 2017

Genovefa Kolovou

1

1 reference

6 August 2017

Deliana Daskalova

series ordinal

2

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

54

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

59-71

1 reference

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Genetic associations with human longevity at the APOE and ACE loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE epsilon2 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

LR11, a mosaic LDL receptor family member, mediates the uptake of ApoE-rich lipoproteins in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Nucleotide sequence and structure of the human apolipoprotein E gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E1 Baden (Arg(180)-->Cys). A new apolipoprotein E variant associated with hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Acute myocardial infarction in young adults: Prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-ter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Is the apoE4 allele an independent predictor of coronary events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158 --> Cys) homozygotes is associated with hyperinsulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

The apolipoprotein epsilon2 allele and the severity of coronary artery disease in Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Lack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E and atherosclerosis: insight from animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Medical utility of apoe allele determination in assessing the need for antioxidant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Molecular bases of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Identification of genes potentially involved in rupture of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

The effect of a gender difference in the apolipoprotein E gene DNA polymorphism on serum lipid levels in a Serbian healthy population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E polymorphisms and age at first coronary artery bypass graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

The relationship between apolipoprotein E, dementia, and vascular illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E epsilon 2 allele and risk of stroke in the older population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E polymorphism in cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Carotid atherosclerosis, vascular risk profile and mortality in a population-based sample of functionally healthy elderly subjects: the Berlin ageing study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E and carotid artery atherosclerosis: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Statins and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Smoking diminishes the beneficial effect of statins: observations from the landmark trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E phenotype regulates cholesterol absorption in healthy 13-month-old children--The STRIP Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Physical activity may modulate effects of ApoE genotype on lipid profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Association of apolipoprotein (Apo)E genotype with plasma apo E levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

The continuous administration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Women have a larger and less atherogenic low density lipoprotein particle size than men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E polymorphism and serum lipoprotein(a) concentrations in a Korean male population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Effects of apoE gene polymorphism on Lp(a) concentrations depend on the size of apo(a): a study of 466 white men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Platelets and lipoprotein (a): a brief overview of their role in the pathogenesis of atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Lipoprotein (a) and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Platelet function and lipid-lowering interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Doxazosin, an alpha1-adrenoceptor antagonist, inhibits serotonin-induced shape change in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Statins and blood pressure regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Beyond LDL-C--the importance of raising HDL-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Apolipoprotein E Alleles and Risk of Coronary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970305400108

10.1177/000331970305400108

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference